RxSight, Inc.
RXST
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
RxSight, Inc., společnost zabývající se lékařskou technologií, se zabývá výzkumem a vývojem, výrobou a prodejem světelně nastavitelných nitroočních čoček (LAL) používaných při operaci šedého zákalu ve Spojených státech a mezinárodně. Nabízí systém RxSight, který lékařům umožňuje přizpůsobit a zvýšit zrakovou ostrost pacientů po operaci šedého zákalu. Systém RxSight společnosti zahrnuje RxSight světelný aplikátor, kancelářský světelný léčebný přístroj, který dodává UV světlo v naprogramovaném vzoru pro úpravu LAL na základě vizuální korekce potřebné k dosažení požadovaného vidění po operaci šedého zákalu. Slouží především lékařům šedého zákalu. Společnost byla dříve známá jako Calhoun Vision, Inc. a v únoru 2017 změnila své jméno na RxSight, Inc. RxSight, Inc. byla založena v roce 1997 a sídlí v Aliso Viejo v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
498
Založení
2021-07-30
Podobné společnosti
$ 13.56
+ $ 0.44
$ 24.82
- $ 0.04
$ 28.26
+ $ 0.66
$ 16.91
- $ 0.10
$ 2.20
- $ 0.04
$ 3.96
- $ 0.50
$ 1.66
- $ 0.06
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 134.5 | 134.5 | 139.9 | 89.1 | 49.0 | 22.6 | 14.7 | 2.2 | |
| Cost of Revenues | 31.5 | 31.5 | 41.0 | 35.3 | 27.7 | 18.1 | 13.0 | 4.1 | |
| Gross Profit | 103.0 | 103.0 | 98.9 | 53.8 | 21.3 | 4.5 | 1.7 | -1.8 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 32.6 | 30.3 | 33.6 | 37.9 | 40.2 | 45.4 | 34.9 | 29.5 | 28.6 | 30.7 | |
| Cost of Revenues | 7.3 | 6.1 | 8.4 | 9.6 | 11.4 | 20.2 | 10.6 | 8.8 | 10.9 | 16.9 | |
| Gross Profit | 25.3 | 24.2 | 25.2 | 28.3 | 28.8 | 25.2 | 24.3 | 20.7 | 17.7 | 13.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 29.1 | 26.0 | 24.5 | 21.9 | 29.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 74.8 | 58.7 | 32.8 | 15.2 | 15.2 | |
| Depreciation & Amortization | -0.8 | -0.8 | 3.6 | 4.2 | 1.5 | 0.1 | 4.6 | 5.7 | |
| Total Operating Expenses | 151.2 | 151.2 | 135.8 | 103.9 | 84.6 | 57.3 | 37.1 | 44.8 | |
| Operating Income | -48.2 | -48.2 | -36.9 | -50.1 | -63.3 | -52.8 | -35.4 | -46.1 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.3 | 7.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.2 | 19.1 | ||
| Depreciation & Amortization | -3.2 | 0.9 | 0.8 | 0.8 | 0.5 | 1.1 | 0.8 | 1.1 | 1.1 | 1.1 | ||
| Total Operating Expenses | 36.6 | 36.4 | 39.2 | 39.0 | 37.4 | 34.4 | 32.6 | 31.4 | 28.5 | 26.2 | ||
| Operating Income | -11.3 | -12.2 | -14.0 | -10.7 | -8.6 | -9.2 | -8.3 | -10.7 | -10.9 | -12.5 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.8 | 2.5 | 9.5 | 6.6 | 1.5 | 0.1 | 0.5 | 2.3 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 3.3 | 4.9 | 3.7 | 0.5 | 0.0 | |
| Other Expense | 9.3 | 9.3 | 9.5 | 1.5 | -3.4 | 4.1 | 63.0 | 172.3 | |
| IBT | -38.9 | -38.9 | -27.4 | -48.6 | -66.7 | -48.7 | 27.6 | 126.2 | |
| Income Tax Expense | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Net Income | -38.9 | -38.9 | -27.5 | -48.6 | -66.8 | -48.7 | 27.6 | 126.2 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 2.3 | 2.5 | 2.7 | 2.9 | 2.3 | 1.6 | 1.7 | 1.7 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | ||
| Other Expense | 2.2 | 2.4 | 2.2 | 2.5 | 2.7 | 2.9 | 2.3 | 1.6 | 1.7 | 0.1 | ||
| IBT | -9.1 | -9.8 | -11.8 | -8.2 | -5.9 | -6.3 | -6.1 | -9.1 | -9.2 | -12.4 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Net Income | -9.2 | -9.8 | -11.8 | -8.2 | -5.9 | -6.3 | -6.1 | -9.1 | -9.2 | -12.4 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.41 | $-2.41 | $-3.57 | $0.18 | $1.39 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.41 | $-2.41 | $-3.57 | $0.18 | $1.39 | |
| Shares Outstanding | 41.2 | 41.2 | 38.9 | 34.5 | 27.7 | 13.6 | 19.1 | 18.8 | |
| Diluted Shares Outstanding | 41.2 | 41.2 | 38.9 | 34.5 | 27.7 | 13.6 | 19.1 | 18.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.26 | $-0.35 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.26 | $-0.35 | ||
| Shares Outstanding | 41.2 | 41.0 | 40.7 | 40.5 | 40.4 | 39.8 | 38.5 | 36.8 | 36.0 | 35.7 | ||
| Diluted Shares Outstanding | 41.2 | 41.0 | 40.7 | 40.5 | 40.4 | 39.8 | 38.5 | 36.8 | 36.0 | 35.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 24.4 | 16.7 | 9.7 | 11.8 | 24.4 | 14.0 | 8.0 | |
| Short Term Investments | 208.8 | 220.5 | 117.5 | 94.0 | 135.0 | 55.0 | 72.7 | |
| Total Cash & ST Investments | 233.3 | 237.2 | 127.2 | 105.8 | 159.3 | 69.0 | 80.7 | |
| Accounts Receivable | 25.7 | 30.1 | 20.3 | 11.0 | 4.9 | 2.9 | 0.8 | |
| Inventory | 19.4 | 22.0 | 17.4 | 14.8 | 8.0 | 8.3 | 7.2 | |
| Other Current Assets | 2.8 | 4.5 | 3.5 | 3.0 | 4.1 | 1.4 | 1.5 | |
| Total Current Assets | 281.2 | 293.8 | 168.4 | 134.6 | 176.3 | 81.5 | 90.2 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 29.6 | 40.4 | 28.0 | 16.7 | 16.7 | 24.4 | 32.6 | 9.7 | 9.9 | 8.8 | |
| Short Term Investments | 197.9 | 187.1 | 201.3 | 220.5 | 220.4 | 208.8 | 92.7 | 117.5 | 122.0 | 138.3 | |
| Total Cash & ST Investments | 227.5 | 227.5 | 229.3 | 237.2 | 237.1 | 233.3 | 125.4 | 127.2 | 131.9 | 147.1 | |
| Accounts Receivable | 24.2 | 28.1 | 31.0 | 30.1 | 25.4 | 25.7 | 21.6 | 20.3 | 15.2 | 13.3 | |
| Inventory | 29.0 | 25.1 | 23.6 | 22.0 | 21.7 | 19.4 | 18.7 | 17.4 | 18.9 | 17.9 | |
| Other Current Assets | 3.3 | 3.3 | 4.5 | 4.5 | 2.6 | 2.8 | 3.0 | 3.5 | 1.9 | 2.1 | |
| Total Current Assets | 283.9 | 283.9 | 288.4 | 293.8 | 286.8 | 281.2 | 168.6 | 168.4 | 167.9 | 180.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 23.3 | 23.6 | 13.3 | 14.1 | 15.5 | 18.6 | 19.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.7 | 0.8 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.3 | 0.4 | 0.1 | 1.5 | 0.9 | 0.6 | 1.0 | |
| Total Long-Term Assets | 24.3 | 24.7 | 14.1 | 15.6 | 16.4 | 19.2 | 20.2 | |
| Total Assets | 305.5 | 318.6 | 182.6 | 150.2 | 192.7 | 100.7 | 110.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 23.4 | 23.8 | 23.5 | 23.6 | 22.8 | 23.3 | 13.7 | 13.3 | 13.1 | 13.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.7 | 0.8 | 0.0 | 0.0 | 0.7 | 0.7 | 0.0 | 0.7 | 0.7 | 0.8 | |
| Other Long-Term Assets | 0.5 | 0.5 | 1.2 | 1.1 | 0.2 | 0.3 | 0.9 | 0.1 | 0.1 | 0.3 | |
| Total Long-Term Assets | 24.7 | 25.1 | 24.6 | 24.7 | 23.7 | 24.3 | 14.6 | 14.1 | 13.9 | 14.8 | |
| Total Assets | 308.5 | 309.0 | 313.0 | 318.6 | 310.5 | 305.5 | 183.2 | 182.6 | 181.9 | 195.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.1 | 4.5 | 3.9 | 2.6 | 1.7 | 1.1 | 2.2 | |
| Short-Term Debt | 0.7 | 1.0 | 1.8 | 2.0 | 1.5 | 1.3 | 1.0 | |
| Other Current Liabilities | 13.8 | 17.2 | 13.2 | 11.3 | 7.2 | 8.8 | 4.9 | |
| Current Liabilities | 19.6 | 25.9 | 20.9 | 17.2 | 11.1 | 11.6 | 8.5 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.4 | 3.3 | 7.1 | 4.5 | 4.6 | 5.1 | 5.1 | 3.9 | 4.1 | 4.0 | |
| Short-Term Debt | 1.3 | 1.1 | 1.1 | 1.0 | 0.7 | 0.7 | 1.6 | 1.8 | 4.0 | 4.0 | |
| Other Current Liabilities | 17.6 | 15.9 | 14.6 | 17.2 | 17.3 | 13.8 | 11.7 | 13.2 | 10.9 | 8.6 | |
| Current Liabilities | 22.3 | 20.4 | 22.7 | 25.9 | 22.6 | 19.6 | 18.3 | 20.9 | 18.9 | 16.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 10.7 | 11.3 | 1.2 | 43.0 | 43.4 | 29.5 | 4.5 | |
| Capital Leases | 10.7 | 12.3 | 3.0 | 4.8 | 5.2 | 6.4 | 5.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 30.3 | 37.3 | 22.2 | 60.3 | 54.5 | 398.2 | 415.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 10.3 | 10.6 | 11.0 | 11.3 | 10.6 | 10.7 | 0.9 | 1.2 | 1.4 | 21.4 | |
| Capital Leases | 0.0 | 11.7 | 12.0 | 12.3 | 11.3 | 10.7 | 2.5 | 1.2 | 3.3 | 3.8 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 32.6 | 31.0 | 33.7 | 37.3 | 33.2 | 30.3 | 19.2 | 22.2 | 20.4 | 38.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 80.8 | 56.4 | |
| Retained Earnings | -609.8 | -622.1 | -594.6 | -546.0 | -479.3 | -430.6 | -419.9 | |
| Comprehensive Income | -0.1 | 0.2 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 275.2 | 281.2 | 160.4 | 89.9 | 138.2 | -297.5 | -304.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -651.9 | -642.1 | -630.3 | -622.1 | -616.2 | -609.8 | -603.7 | -594.6 | -585.5 | -573.0 | |
| Comprehensive Income | 0.1 | -0.1 | 0.0 | 0.2 | 0.5 | -0.1 | -0.1 | 0.0 | -0.1 | -0.1 | |
| Total Common Equity | 276.0 | 278.0 | 279.3 | 281.2 | 277.3 | 275.2 | 163.9 | 160.4 | 161.5 | 157.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Debt | 11.4 | 12.3 | 3.0 | 45.0 | 44.9 | 30.8 | 5.5 | |
| Book Value | 275.2 | 281.2 | 160.4 | 89.9 | 138.2 | -297.5 | -304.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 276.0 | 278.0 | 279.3 | 281.2 | 277.3 | 275.2 | 163.9 | 160.4 | 161.5 | 157.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -36.8 | 0.0 | -27.5 | -48.6 | -66.8 | -48.7 | 27.6 | 126.2 | |
| Depreciation & Amortization | 4.2 | 0.0 | 3.6 | 4.2 | 4.0 | 4.0 | 4.0 | 3.9 | |
| Stock-Based Compensation | 19.3 | 0.0 | 24.6 | 15.7 | 11.4 | 7.6 | 4.2 | 4.6 | |
| Change Working Capital | -11.3 | -4.9 | -9.2 | -9.1 | -7.4 | -2.7 | -7.8 | -4.0 | |
| Change In Accounts Receivable | -12.4 | 6.7 | -9.8 | -9.3 | -6.1 | -2.0 | -2.1 | -0.8 | |
| Change In Accounts Payable | 0.7 | 0.6 | 0.9 | 1.3 | 0.6 | 0.6 | -1.0 | 1.1 | |
| Change In Inventories | -1.8 | -11.5 | -5.0 | -2.7 | -7.6 | -2.1 | -1.3 | -5.5 | |
| Other Non-cash Items | 25.5 | -10.6 | -8.5 | -3.9 | -0.1 | 0.5 | 0.1 | -171.4 | |
| Cash from Operations | -31.3 | 0.0 | 0.0 | -41.6 | -58.9 | -44.7 | -35.2 | -40.6 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 29.8 | -9.8 | -11.8 | -8.2 | -5.9 | -6.3 | -6.1 | -9.1 | -9.2 | -12.4 | |
| Depreciation & Amortization | -2.4 | 0.9 | 0.8 | 0.8 | 0.5 | 1.1 | 0.8 | 1.1 | 1.1 | 1.1 | |
| Stock-Based Compensation | -23.8 | 8.1 | 8.5 | 7.1 | 7.3 | 6.6 | 6.1 | 4.7 | 4.4 | 4.1 | |
| Change Working Capital | 0.6 | 1.7 | -1.0 | -6.2 | -3.6 | 1.9 | -2.9 | -4.7 | -3.2 | -0.6 | |
| Change In Accounts Receivable | 0.8 | 3.9 | 2.9 | -0.9 | -4.7 | 0.3 | -4.2 | -1.3 | -5.0 | -2.0 | |
| Change In Accounts Payable | 2.2 | -0.1 | -3.7 | 2.2 | 0.1 | 0.0 | -0.4 | 1.2 | -0.2 | 0.1 | |
| Change In Inventories | -3.2 | -4.0 | -2.7 | -1.6 | -0.4 | -2.4 | -0.8 | -1.4 | 1.4 | -1.0 | |
| Other Non-cash Items | -5.3 | -2.1 | -0.9 | -2.4 | -2.6 | -2.5 | -2.1 | -1.4 | 7.4 | 0.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -9.9 | -8.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -5.7 | -3.8 | -5.4 | -4.8 | -2.4 | -1.9 | -2.5 | -4.1 | |
| Acquisitions | -24.1 | 0.0 | 0.0 | 17.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -322.8 | -239.3 | -336.9 | -272.3 | -212.7 | -160.0 | -97.9 | -132.4 | |
| Sales of Investment | 259.0 | 260.0 | 243.0 | 255.0 | 255.0 | 80.0 | 116.0 | 130.0 | |
| Other Investing Activities | -63.8 | 0.0 | 0.0 | -17.3 | 0.0 | 0.0 | 0.0 | 0.6 | |
| Cash from Investing | -69.5 | 0.0 | 0.0 | -22.1 | 40.0 | -81.9 | 15.6 | -5.9 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 2.7 | -0.6 | -1.5 | -0.6 | -0.8 | -1.1 | -1.5 | -2.0 | -1.6 | -0.7 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.2 | -17.9 | |
| Investments | 140.8 | -68.4 | -33.8 | -38.6 | -52.8 | -77.2 | -159.1 | -47.8 | -43.8 | -72.1 | |
| Sales of Investment | -170.0 | 60.0 | 50.0 | 60.0 | 55.0 | 69.0 | 45.0 | 74.0 | 50.0 | 90.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.2 | 17.9 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 | 17.3 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -22.3 | 0.0 | 0.0 | -40.2 | -0.1 | 0.0 | -0.1 | -0.2 | |
| Debt Issued | 10.3 | 12.3 | 9.3 | -1.8 | 0.2 | 14.2 | 25.4 | 5.7 | |
| Issuance of Common Stock | 138.6 | 0.0 | 0.0 | 106.0 | 6.1 | 119.6 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 2.3 | 0.0 | 0.0 | -4.3 | 0.4 | 17.8 | 25.4 | 1.5 | |
| Cash from Financing | 116.5 | 0.0 | 0.0 | 61.5 | 6.3 | 137.3 | 25.2 | 1.3 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -20.0 | |
| Debt Issued | 11.6 | -0.2 | -0.3 | -0.3 | 1.0 | -0.1 | 8.9 | -0.5 | -0.3 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 13.9 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.2 | -8.2 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 15.6 | 3.2 | 7.1 | -2.2 | -12.6 | 10.7 | 5.6 | -45.2 | |
| Closing Cash Balance | 24.4 | 19.9 | 17.5 | 10.4 | 12.6 | 25.2 | 14.5 | 8.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -9.7 | -10.7 | 12.4 | 11.3 | 0.0 | -7.7 | -8.2 | 23.0 | -0.2 | 1.1 | |
| Closing Cash Balance | 19.9 | 30.4 | 41.1 | 28.8 | 17.5 | 17.4 | 24.4 | 33.4 | 9.7 | 10.6 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -37.0 | -19.3 | -22.4 | -46.4 | -61.2 | -46.6 | -37.7 | -44.7 | |
| Real Free Cash Flow | -56.3 | -19.3 | -47.0 | -62.2 | -72.6 | -54.2 | -41.9 | -49.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 17.1 | -1.8 | -5.9 | -9.4 | -5.1 | -0.4 | -5.6 | -11.3 | -11.5 | -8.6 | |
| Real Free Cash Flow | 40.9 | -9.9 | -14.5 | -16.5 | -12.4 | -6.9 | -11.7 | -16.0 | -15.9 | -12.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -6.8 | -20.2 | 179.3 |
| P/S | 2 | 10.9 | 390.6 |
| P/B | 1 | 4 | 113.4 |
| P/FCF | 0 | -13.7 | 149.9 |
| Market cap | $0.4 | $2.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 3.7 % | 14.5 % | 0 % |
| Debt to Income | -29.7 % | -46.5 % | 0 % |
| Debt to Free cash flow | 0 % | -461.8 % | 0 % |
| Interest expense percentage | -0 % | -3.8 % | 11.2 % |
| Current ratio | 12.7 | 10.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -14.1 % | -24.9 % | 0 % |
| ROA | -12.6 % | -12.8 % | 0 % |
| CapEx to Revenue | 2.5 % | 9.1 % | 6 % |
| RaD to Revenue | 0 % | 78.5 % | 0 % |
| ROEM | 270,038.2 | 48203.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 75 % | 38.8 % | 61.9 % |
| Operating margin | -32 % | -144 % | 17.9 % |
| Net margin | -25.1 % | -82.3 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0.1 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 41.0 mil | 30.2 mil |
| Employee count | 0.5 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
